返回
BioDlink International Company Limited（01875.HK）价格
01875.HK 股价走势图
BIODLINK-B (01875.HK)
BioDlink International Company Limited
HK$4.26
-5.33%
$-0.24
休市： Jan 16, 16:00:00 HKT
暂无数据Follow-Up Questions
BioDlink International Company Limited 的关键财务报表是什么？
01875.HK 的关键财务比率是什么？
BioDlink International Company Limited 的收入按细分市场或地理位置如何划分？
BioDlink International Company Limited 是否盈利？
BioDlink International Company Limited 有负债吗？
BioDlink International Company Limited 的流通股有多少？
关键数据
前收盘价
$4.19
开盘价
$4.5
当日区间
$4.21 - $4.66
52周范围
$1.52 - $4.26
交易量
35.2M
平均成交量
141.4K
每股收益（TTM）
0.02
股息收益率
--
市值
$3.0B
什么是 BIODLINK-B？
BioDlink International Co., Ltd. is clinical stage biopharmaceutical company, which engages in developing and commercializing oncology drugs and therapies. The company is headquartered in Suzhou, Jiangsu and currently employs 604 full-time employees. The company went IPO on 2019-11-08. The firm and its subsidiaries are primarily engaged in research, development, manufacturing, and marketing of anti-tumor drugs, contract development and manufacturing organization (CDMO) business and license-out of self-developed biological drugs in the People’s Republic of China. The firm owns a pipeline of oncology drug candidates, which include monoclonal antibodies (mAbs) and antibody-drug conjugates (ADCs). The firm has built and established a fully integrated in-house platform of discovery, process development, quality management, pre-clinical and clinical development, as well as commercial-scale manufacturing facilities and sales and marketing capabilities. The firm mainly conducts its businesses in the domestic market.